Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Combination lovastatin and probucol reduced total cholesterol (27%) and low-density lipoprotein levels (30%), but did not prevent restenosis or clinical events during the first 6 months after percutaneous transluminal coronary angioplasty.